Statement Of Financial Position [Abstract]

BerGenBio - Filing #2542730

Concept As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
As at
2021-12-31
Statement of financial position [abstract]
Assets [abstract]
Cash and cash equivalents
156,421,000 NOK
150,803,000 NOK
436,646,000 NOK
Assets
174,335,000 NOK
166,706,000 NOK
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
268,869,000 NOK
8,866,000 NOK
Retained earnings
189,234,000 NOK
0 NOK
Share premium
854,000 NOK
35,780,000 NOK
Equity
854,000 NOK
268,869,000 NOK
189,234,000 NOK
46,987,000 NOK
127,476,000 NOK
88,498,000 NOK
35,780,000 NOK
0 NOK
8,866,000 NOK
43,852,000 NOK
0 NOK
384,426,000 NOK
40,386,000 NOK
335,195,000 NOK
8,846,000 NOK
Liabilities [abstract]
Liabilities
46,859,000 NOK
78,208,000 NOK
Equity and liabilities
174,335,000 NOK
166,706,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.